臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"pei jer chen"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 571-595 / 883 (共36頁)
<< < 18 19 20 21 22 23 24 25 26 27 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2021-07-03T03:33:54Z	Hepatocellular carcinoma and hepatitis C virus	Wang S.-H.;Yeh S.-H.;Pei-Jer Chen; Wang S.-H.; Yeh S.-H.; PEI-JER CHEN
臺大學術典藏	2021-07-03T03:33:53Z	Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen	Zhang T.-Y.;Yuan Q.;Zhao J.-H.;Zhang Y.-L.;Yuan L.-Z.;Lan Y.;Lo Y.-C.;Sun C.-P.;Wu C.-R.;Zhang J.-F.;Zhang Y.;Cao J.-L.;Guo X.-R.;Liu X.;Mo X.-B.;Luo W.-X.;Cheng T.;Chen Y.-X.;Tao M.-H.;Shih J.W.K.;Zhao Q.-J.;Zhang J.;Pei-Jer Chen;Yuan Y.A.;Xia N.-S.; Zhang T.-Y.; Yuan Q.; Zhao J.-H.; Zhang Y.-L.; Yuan L.-Z.; Lan Y.; Lo Y.-C.; Sun C.-P.; Wu C.-R.; Zhang J.-F.; Zhang Y.; Cao J.-L.; Guo X.-R.; Liu X.; Mo X.-B.; Luo W.-X.; Cheng T.; Chen Y.-X.; Tao M.-H.; Shih J.W.K.; Zhao Q.-J.; Zhang J.; PEI-JER CHEN; Yuan Y.A.; Xia N.-S.
臺大學術典藏	2021-07-03T03:33:53Z	Health-related quality of life in thrombocytopenic patients with chronic hepatitis C with or without cirrhosis in the ENABLE-1 and ENABLE-2 studies	Grotzinger K.M.;Younossi Z.M.;Giannini E.G.;Pei-Jer Chen;Rendas-Baum R.;Theodore D.; Grotzinger K.M.; Younossi Z.M.; Giannini E.G.; PEI-JER CHEN; Rendas-Baum R.; Theodore D.
臺大學術典藏	2021-07-03T03:33:53Z	Hepatitis B surface antigen loss and hepatocellular carcinoma development in patients with dual hepatitis B and C infection	Yang W.-T.;Wu L.-W.;Tseng T.-C.;Chen C.-L.;Yang H.-C.;Su T.-H.;Wang C.-C.;Kuo S.F.-T.;Liu C.-H.;Pei-Jer Chen;Chen D.-S.;Liu C.-J.;Kao J.-H.; Yang W.-T.; Wu L.-W.; Tseng T.-C.; Chen C.-L.; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Liu C.-J.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:52Z	Perspectives on dual hepatitis B and C infection in Taiwan	Liu C.-J.;Pei-Jer Chen;Chen D.-S.;Tseng T.-C.;Kao J.-H.; Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Tseng T.-C.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:52Z	Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B)	Chan H.L.Y.;Ahn S.H.;Chang T.-T.;Peng C.-Y.;Wong D.;Coffin C.S.;Lim S.G.;Pei-Jer Chen;Janssen H.L.A.;Marcellin P.;Serfaty L.;Zeuzem S.;Cohen D.;Critelli L.;Xu D.;Wind-Rotolo M.;Cooney E.;Lira-B Study Team; Chan H.L.Y.; Ahn S.H.; Chang T.-T.; Peng C.-Y.; Wong D.; Coffin C.S.; Lim S.G.; PEI-JER CHEN; Janssen H.L.A.; Marcellin P.; Serfaty L.; Zeuzem S.; Cohen D.; Critelli L.; Xu D.; Wind-Rotolo M.; Cooney E.; LIRA-B Study Team
臺大學術典藏	2021-07-03T03:33:52Z	The Hepatitis Viral Status in Patients with Hepatocellular Carcinoma: A Study of 3843 Patients from Taiwan Liver Cancer Network	Chang I.-C.;Huang S.-F.;Pei-Jer Chen;Chen C.-L.;Chen C.-L.;Wu C.-C.;Tsai C.-C.;Lee P.-H.;Chen M.-F.;Lee C.-M.;Yu H.-C.;Lo G.-H.;Yeh C.-T.;Hong C.-C.;Eng H.-L.;Wang J.;Tseng H.-H.;Hsiao C.-H.;Wu H.-D.I.;Yen T.-C.;Liaw Y.-F.; Chang I.-C.; Huang S.-F.; PEI-JER CHEN; Chen C.-L.; Chen C.-L.; Wu C.-C.; Tsai C.-C.; Lee P.-H.; Chen M.-F.; Lee C.-M.; Yu H.-C.; Lo G.-H.; Yeh C.-T.; Hong C.-C.; Eng H.-L.; Wang J.; Tseng H.-H.; Hsiao C.-H.; Wu H.-D.I.; Yen T.-C.; Liaw Y.-F.
臺大學術典藏	2021-07-03T03:33:51Z	Hypoxia-activated cytotoxic agent tirapazamine enhances hepatic artery ligation-induced killing of liver tumor in HBx transgenic mice	Lin W.-H.;Yeh S.-H.;Yeh K.-H.;Chen K.-W.;Cheng Y.-W.;Su T.-H.;Jao P.;Ni L.-C.;Pei-Jer Chen;Chen D.-S.; Lin W.-H.; Yeh S.-H.; Yeh K.-H.; Chen K.-W.; Cheng Y.-W.; Su T.-H.; Jao P.; Ni L.-C.; PEI-JER CHEN; Chen D.-S.
臺大學術典藏	2021-07-03T03:33:51Z	Progressive accumulation of mutations in the hepatitis B virus genome and its impact on time to diagnosis of hepatocellular carcinoma	Sung F.-Y.;Lan C.-Y.;Huang C.-J.;Lin C.-L.;Liu C.-J.;Pei-Jer Chen;Lin S.-M.;Yu M.-W.; Sung F.-Y.; Lan C.-Y.; Huang C.-J.; Lin C.-L.; Liu C.-J.; PEI-JER CHEN; Lin S.-M.; Yu M.-W.
臺大學術典藏	2021-07-03T03:33:51Z	Liver gene expression profiles correlate with virus infection and response to interferon therapy in chronic hepatitis B patients	Wu H.-L.;Hsiao T.-H.;Pei-Jer Chen;Wong S.-H.;Kao J.-H.;Chen D.-S.;Lu J.-Y.;Lu T.-P.;Chen Y.;Chuang E.Y.;Tu H.-C.;Liu C.-J.; Wu H.-L.; Hsiao T.-H.; PEI-JER CHEN; Wong S.-H.; Kao J.-H.; Chen D.-S.; Lu J.-Y.; Lu T.-P.; Chen Y.; Chuang E.Y.; Tu H.-C.; Liu C.-J.
臺大學術典藏	2021-07-03T03:33:50Z	A novel toolbox for the in vitro assay of hepatitis D virus infection	Zhao J.-H.; Zhang Y.-L.; Zhang T.-Y.; Yuan L.-Z.; Cheng T.; PEI-JER CHEN; Yuan Q.; Xia N.-S.
臺大學術典藏	2021-07-03T03:33:50Z	Management of hepatitis C virus infection in the Asia-Pacific region: an update	Lim S.G.; Aghemo A.; PEI-JER CHEN; Dan Y.Y.; Gane E.; Gani R.; Gish R.G.; Guan R.; Jia J.D.; Lim K.; Piratvisuth T.; Shah S.; Shiffman M.L.; Tacke F.; Tan S.S.; Tanwandee T.; Win K.M.; Yurdaydin C.
臺大學術典藏	2021-07-03T03:33:50Z	Hydrodynamic HBV transfection mouse model	Wu L.-L.; Wang H.-Y.; PEI-JER CHEN
臺大學術典藏	2021-07-03T03:33:50Z	Prevalence and clinical implications of IL28B genotypes in Taiwanese patients with chronic hepatitis C	Mah Y.-H.;Liu C.-H.;Chen C.-L.;Tseng T.-C.;Liu C.-J.;Pei-Jer Chen;Chen D.-S.;Kao J.-H.; Mah Y.-H.; Liu C.-H.; Chen C.-L.; Tseng T.-C.; Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:49Z	One-Pot Two-Nanoprobe Assay Uncovers Targeted Glycoprotein Biosignature	Chen Y.-J.; Dela Rosa M.A.C.; Chen W.-C.; Chen Y.-J.; Obena R.P.; Chang C.-H.; Capangpangan R.Y.; Su T.-H.; Chen C.-L.; PEI-JER CHEN
臺大學術典藏	2021-07-03T03:33:49Z	Addition of ribavirin to daclatasvir plus asunaprevir for chronic hepatitis C 1b patients with baseline NS5A resistance-associated variants improved response	Hong C.-M.; Liu C.-J.; Yeh S.-H.; PEI-JER CHEN
臺大學術典藏	2021-07-03T03:33:49Z	Corrigendum to “Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma” (Journal of Hepatology (2011) 55(5) (1041–1048)(S0168827811001917)(10.1016/j.jhep.2011.01.047))	Tai W.-T.; Cheng A.-L.; Shiau C.-W.; Huang H.-P.; Huang J.-W.; PEI-JER CHEN; Chen K.-F.
臺大學術典藏	2021-07-03T03:33:49Z	Genome-wide identification of blood DNA methylation patterns associated with early-onset hepatocellular carcinoma development in hepatitis B carriers	Kao W.-Y.; Yang S.-H.; Liu W.-J.; Yeh M.-Y.; Lin C.-L.; Liu C.-J.; Huang C.-J.; Lin S.-M.; Lee S.-D.; PEI-JER CHEN; Yu M.-W.
臺大學術典藏	2021-07-03T03:33:48Z	A phase I/II multicenter study of single-agent foretinib as first-line therapy in patients with advanced hepatocellular carcinoma	Yau T.C.C.; Lencioni R.; Sukeepaisarnjaroen W.; Chao Y.; Yen C.-J.; Lausoontornsiri W.; PEI-JER CHEN; Sanpajit T.; Camp A.; Cox D.S.; Gagnon R.C.; Liu Y.; Raffensperger K.E.; Kulkarni D.A.; Kallender H.; Ottesen L.H.; Poon R.T.P.; Bottaro D.P.
臺大學術典藏	2021-07-03T03:33:48Z	De novo assembly of highly polymorphic metagenomic data using in situ generated reference sequences and a novel BLAST-based assembly pipeline	Lin Y.-Y.; Hsieh C.-H.; Chen J.-H.; Lu X.; Kao J.-H.; PEI-JER CHEN; Chen D.-S.; Wang H.-Y.
臺大學術典藏	2021-07-03T03:33:48Z	Prescription patterns of sorafenib and outcomes of patients with advanced hepatocellular carcinoma: A national population study	Lu L.-C.; PEI-JER CHEN; Yeh Y.-C.; Hsu C.-H.; Chen H.-M.; Lai M.-S.; Shao Y.-Y.; Cheng A.-L.
臺大學術典藏	2021-07-03T03:33:47Z	Corrigendum to “Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma” (Journal of Hepatology (2017) 66(3) (666–668) (S0168827816307127) (10.1016/j.jhep.2016.12.007))	Tai W.-T.; Cheng A.-L.; Shiau C.-W.; Huang H.-P.; Huang J.-W.; PEI-JER CHEN; Chen K.-F.
臺大學術典藏	2021-07-03T03:33:47Z	Chronologic changes in serum hepatitis B virus DNA, genotypes, surface antigen mutants and reverse transcriptase mutants during 25-year nationwide immunization in Taiwan	Hsu H.-Y.; Chang M.-H.; Ni Y.-H.; Chiang C.-L.; Wu J.-F.; Chen H.-L.; PEI-JER CHEN; Chen D.-S.
臺大學術典藏	2021-07-03T03:33:47Z	Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update	Omata M.; Cheng A.-L.; Kokudo N.; Kudo M.; Lee J.M.; Jia J.; Tateishi R.; Han K.-H.; Chawla Y.K.; Shiina S.; Jafri W.; Payawal D.A.; Ohki T.; Ogasawara S.; PEI-JER CHEN; Lesmana C.R.A.; Lesmana L.A.; Gani R.A.; Obi S.; Dokmeci A.K.; Sarin S.K.
臺大學術典藏	2021-07-03T03:33:47Z	Peg-interferon lambda treatment induces robust innate and adaptive immunity in chronic hepatitis B patients	Phillips S.; Mistry S.; Riva A.; Cooksley H.; Hadzhiolova-Lebeau T.; Plavova S.; Katzarov K.; Simonova M.; Zeuzem S.; Woffendin C.; PEI-JER CHEN; Peng C.-Y.; Chang T.-T.; Lueth S.; Knegt R.D.; Choi M.-S.; Wedemeyer H.; Dao M.; Kim C.-W.; Chu H.-C.; Wind-Rotolo M.; Williams R.; Cooney E.; Chokshi S.

顯示項目 571-595 / 883 (共36頁)
<< < 18 19 20 21 22 23 24 25 26 27 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :2822924
	造訪人次 : 30034148 線上人數 : 1216 教育部委託研究計畫計畫執行:國立臺灣大學圖書館